Skip to main content

Advertisement

SpringerLink
Log in

Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents

  • SHORT REPORT
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T (2007) Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol 63(1):16–28

    Article  PubMed  Google Scholar 

  2. Shim K, MacKenzie MJ, Winquist E (2008) Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf 31(5):359–371

    Article  PubMed  CAS  Google Scholar 

  3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239–245

    Article  PubMed  CAS  Google Scholar 

  4. Guillet M, Walter T, Scoazec JY, Vial T, Lombard-Bohas C, Dumortier J (2009) Sorafenib-Induced Bilateral Osteonecrosis of Femoral Heads. J Clin Oncol

  5. Kabata T, Matsumoto T, Yagishita S, Wakayama T, Iseki S, Tomita K (2008) Vascular endothelial growth factor in rabbits during development of corticosteroid-induced osteonecrosis: a controlled experiment. J Rheumatol 35(12):2383–2390

    Article  PubMed  Google Scholar 

  6. Varoga D, Drescher W, Pufe M, Groth G, Pufe T (2009) Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head. Clin Orthop Relat Res 467(12):3273–3282

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Medical Oncology CERIA (Centre for Research on Angiogenesis Inhibitors), Université Paris Descartes, AP-HP, Teaching Hospital Cochin, 27, rue du faubourg Saint Jacques, F75014, Paris, France

    Olivier Mir, Romain Coriat, Stanislas Ropert, Bertrand Billemont & François Goldwasser

  2. Teaching European Hospital Georges Pompidou, Department of Orthopaedic Surgery, Université Paris Descartes, AP-HP, Paris, France

    Thomas Gregory

Authors
  1. Olivier Mir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Romain Coriat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Gregory
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stanislas Ropert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bertrand Billemont
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. François Goldwasser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olivier Mir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mir, O., Coriat, R., Gregory, T. et al. Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents. Invest New Drugs 29, 716–718 (2011). https://doi.org/10.1007/s10637-010-9406-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-010-9406-6

Keywords

Search

Navigation